Viewing Study NCT00099905


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-05-15 @ 5:19 PM
Study NCT ID: NCT00099905
Status: COMPLETED
Last Update Posted: 2012-05-02
First Post: 2004-12-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None vildagliptin View